# Lightwave Logic, Inc.: financial statements, quarterly

LWLG · Nasdaq · CIK 1325964 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lwlg.md) · [Financials](/companies/lwlg/financials.md) · [Filings](/companies/lwlg/filings.md) · [Insiders](/companies/lwlg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lwlg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [0.0](/filings/0001079973-23-001541.md) | [40.5 d](/filings/0001079973-25-000420.md) | [30.4](/filings/0001079973-25-000793.md) | [19.4](/filings/0001079973-26-000097.md) | [22.9](/filings/0001079973-25-001745.md) | [22.9 d](/filings/0001079973-26-000348.md) | [22.9](/filings/0001553350-26-000087.md) | [25.6](/filings/0001079973-26-001097.md) | [29.2](/filings/0001079973-25-001745.md) | [159 d](/filings/0001079973-26-000348.md) | [29.2](/filings/0001553350-26-000087.md) | [32.8](/filings/0001079973-26-001097.md) |
| Cost of revenue | $k | not reported | not reported | [5.2](/filings/0001079973-25-000793.md) | [0.0 d](/filings/0001079973-26-000097.md) | [1.2](/filings/0001079973-25-001745.md) | [1.0 d](/filings/0001079973-26-000348.md) | [2.0](/filings/0001553350-26-000087.md) | [3.5](/filings/0001079973-26-001097.md) | [0.0 d](/filings/0001079973-25-001745.md) | [1.3 d](/filings/0001079973-26-000348.md) | [1.3](/filings/0001553350-26-000087.md) | [0.0 d](/filings/0001079973-26-001097.md) |
| Gross profit | $k | not reported | not reported | [25.2](/filings/0001079973-25-000793.md) | not reported | not reported | not reported | [20.9](/filings/0001079973-25-000793.md) | not reported | not reported | not reported | not reported | not reported |
| Research and development | $k | [4,041](/filings/0001079973-24-001503.md) | [3,897 d](/filings/0001079973-25-000420.md) | [4,621](/filings/0001079973-25-000793.md) | [4,362](/filings/0001079973-26-000097.md) | [3,828](/filings/0001079973-25-001745.md) | [3,995 d](/filings/0001079973-26-000348.md) | [3,089](/filings/0001553350-26-000087.md) | [2,621](/filings/0001079973-26-001097.md) | [2,917](/filings/0001079973-25-001745.md) | [2,841 d](/filings/0001079973-26-000348.md) | [3,490](/filings/0001553350-26-000087.md) | [3,879](/filings/0001079973-26-001097.md) |
| Operating income | $k | [(5,386)](/filings/0001079973-24-001503.md) | [(5,339) d](/filings/0001079973-25-000420.md) | [(5,851)](/filings/0001079973-25-000793.md) | [(6,240)](/filings/0001079973-26-000097.md) | [(5,297)](/filings/0001079973-25-001745.md) | [(5,702) d](/filings/0001079973-26-000348.md) | [(4,905)](/filings/0001553350-26-000087.md) | [(4,900)](/filings/0001079973-26-001097.md) | [(5,179)](/filings/0001079973-25-001745.md) | [(5,071) d](/filings/0001079973-26-000348.md) | [(6,725)](/filings/0001553350-26-000087.md) | [(7,269)](/filings/0001079973-26-001097.md) |
| Interest expense | $k | [25.3](/filings/0001079973-23-001541.md) | [65.9 d](/filings/0001079973-24-000315.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [0.0](/filings/0001079973-24-001503.md) | not reported | [0.0](/filings/0001079973-25-000793.md) | [0.0](/filings/0001079973-26-000097.md) | [0.0](/filings/0001079973-25-001745.md) | not reported | [0.0](/filings/0001553350-26-000087.md) | [0.0](/filings/0001079973-26-001097.md) | [0.0](/filings/0001079973-25-001745.md) | not reported | [0.0](/filings/0001553350-26-000087.md) | [0.0](/filings/0001079973-26-001097.md) |
| Net income | $k | [(5,165)](/filings/0001079973-24-001503.md) | [(4,940) d](/filings/0001079973-25-000420.md) | [(5,680)](/filings/0001079973-25-000793.md) | [(6,020)](/filings/0001079973-26-000097.md) | [(5,301)](/filings/0001079973-25-001745.md) | [(5,535) d](/filings/0001079973-26-000348.md) | [(4,697)](/filings/0001553350-26-000087.md) | [(4,967)](/filings/0001079973-26-001097.md) | [(5,101)](/filings/0001079973-25-001745.md) | [(4,844) d](/filings/0001079973-26-000348.md) | [(6,301)](/filings/0001553350-26-000087.md) | [(6,614)](/filings/0001079973-26-001097.md) |
| Diluted EPS | $ per share | [(0.04)](/filings/0001079973-24-001503.md) | not reported | [(0.05)](/filings/0001079973-25-000793.md) | [(0.05)](/filings/0001079973-26-000097.md) | [(0.04)](/filings/0001079973-25-001745.md) | not reported | [(0.04)](/filings/0001553350-26-000087.md) | [(0.04)](/filings/0001079973-26-001097.md) | [(0.04)](/filings/0001079973-25-001745.md) | not reported | [(0.04)](/filings/0001553350-26-000087.md) | [(0.04)](/filings/0001079973-26-001097.md) |
| Basic EPS | $ per share | [(0.04)](/filings/0001079973-24-001503.md) | not reported | [(0.05)](/filings/0001079973-25-000793.md) | [(0.05)](/filings/0001079973-26-000097.md) | [(0.04)](/filings/0001079973-25-001745.md) | not reported | [(0.04)](/filings/0001553350-26-000087.md) | [(0.04)](/filings/0001079973-26-001097.md) | [(0.04)](/filings/0001079973-25-001745.md) | not reported | [(0.04)](/filings/0001553350-26-000087.md) | [(0.04)](/filings/0001079973-26-001097.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [30.9](/filings/0001079973-23-001541.md) | [31.4](/filings/0001079973-25-000420.md) | [31.5](/filings/0001553350-24-000021.md) | [29.2](/filings/0001079973-24-001191.md) | [26.9](/filings/0001079973-24-001503.md) | [27.7](/filings/0001079973-26-000348.md) | [25.0](/filings/0001079973-25-000793.md) | [22.1](/filings/0001079973-26-000097.md) | [34.9](/filings/0001079973-25-001745.md) | [69.0](/filings/0001079973-26-001097.md) | [75.1](/filings/0001553350-26-000087.md) | [47.2](/filings/0001079973-26-001097.md) |
| Current assets | $m | [31.4](/filings/0001079973-23-001541.md) | [32.7](/filings/0001079973-25-000420.md) | [32.3](/filings/0001553350-24-000021.md) | [30.0](/filings/0001079973-24-001191.md) | [27.5](/filings/0001079973-24-001503.md) | [28.1](/filings/0001079973-26-000348.md) | [25.6](/filings/0001079973-25-000793.md) | [22.8](/filings/0001079973-26-000097.md) | [35.5](/filings/0001079973-25-001745.md) | [69.8](/filings/0001079973-26-001097.md) | [76.5](/filings/0001553350-26-000087.md) | [98.1](/filings/0001079973-26-001097.md) |
| Total assets | $m | [39.1](/filings/0001079973-23-001541.md) | [41.8](/filings/0001079973-25-000420.md) | [41.7](/filings/0001553350-24-000021.md) | [39.8](/filings/0001079973-24-001191.md) | [37.2](/filings/0001079973-24-001503.md) | [37.8](/filings/0001079973-26-000348.md) | [35.6](/filings/0001079973-25-000793.md) | [32.4](/filings/0001079973-26-000097.md) | [44.8](/filings/0001079973-25-001745.md) | [79.2](/filings/0001079973-26-001097.md) | [85.9](/filings/0001553350-26-000087.md) | [108](/filings/0001079973-26-001097.md) |
| Current liabilities | $m | [0.9](/filings/0001079973-23-001541.md) | [2.6](/filings/0001079973-25-000420.md) | [1.8](/filings/0001553350-24-000021.md) | [1.5](/filings/0001079973-24-001191.md) | [1.1](/filings/0001079973-24-001503.md) | [1.8](/filings/0001079973-26-000348.md) | [1.5](/filings/0001079973-25-000793.md) | [1.1](/filings/0001079973-26-000097.md) | [1.1](/filings/0001079973-25-001745.md) | [2.1](/filings/0001079973-26-001097.md) | [2.3](/filings/0001553350-26-000087.md) | [1.6](/filings/0001079973-26-001097.md) |
| Total liabilities | $m | [3.7](/filings/0001079973-23-001541.md) | [5.3](/filings/0001079973-25-000420.md) | [4.5](/filings/0001553350-24-000021.md) | [4.2](/filings/0001079973-24-001191.md) | [3.8](/filings/0001079973-24-001503.md) | [4.4](/filings/0001079973-26-000348.md) | [4.1](/filings/0001079973-25-000793.md) | [3.6](/filings/0001079973-26-000097.md) | [3.6](/filings/0001079973-25-001745.md) | [4.5](/filings/0001079973-26-001097.md) | [4.6](/filings/0001553350-26-000087.md) | [3.9](/filings/0001079973-26-001097.md) |
| Shareholders' equity | $m | [35.4](/filings/0001079973-24-001503.md) | [36.4](/filings/0001079973-26-000348.md) | [37.2](/filings/0001079973-26-000097.md) | [35.6](/filings/0001079973-26-000097.md) | [33.5](/filings/0001079973-25-001745.md) | [33.4](/filings/0001079973-26-001097.md) | [31.5](/filings/0001079973-26-001097.md) | [28.8](/filings/0001079973-26-001097.md) | [41.2](/filings/0001079973-25-001745.md) | [74.6](/filings/0001079973-26-001097.md) | [81.3](/filings/0001079973-26-001097.md) | [104](/filings/0001079973-26-001097.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(2,910) d](/filings/0001079973-24-001503.md) | [(2,322) d](/filings/0001079973-25-000420.md) | [(4,772)](/filings/0001079973-25-000793.md) | [(4,052) d](/filings/0001079973-26-000097.md) | [(3,590) d](/filings/0001079973-25-001745.md) | [(3,136) d](/filings/0001079973-26-000348.md) | [(3,490)](/filings/0001553350-26-000087.md) | [(3,770) d](/filings/0001079973-26-001097.md) | [(3,176) d](/filings/0001079973-25-001745.md) | [(3,313) d](/filings/0001079973-26-000348.md) | [(4,061)](/filings/0001553350-26-000087.md) | [(5,821) d](/filings/0001079973-26-001097.md) |
| Capital expenditure | $k | [835 d](/filings/0001079973-24-001503.md) | [1,478 d](/filings/0001079973-25-000420.md) | [775](/filings/0001079973-25-000793.md) | [810 d](/filings/0001079973-26-000097.md) | [350 d](/filings/0001079973-25-001745.md) | [332 d](/filings/0001079973-26-000348.md) | [854](/filings/0001553350-26-000087.md) | [40.4 d](/filings/0001079973-26-001097.md) | [59.3 d](/filings/0001079973-25-001745.md) | [379 d](/filings/0001079973-26-000348.md) | [450](/filings/0001553350-26-000087.md) | [1,068 d](/filings/0001079973-26-001097.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [112](/filings/0001079973-23-001541.md) | [113](/filings/0001553350-24-000021.md) | [115](/filings/0001079973-24-001191.md) | [116](/filings/0001079973-24-001503.md) | [119](/filings/0001079973-25-000793.md) | [120](/filings/0001079973-26-000097.md) | [121](/filings/0001079973-25-001745.md) | [124](/filings/0001553350-26-000087.md) | [125](/filings/0001079973-26-001097.md) | [130](/filings/0001079973-25-001745.md) | [148](/filings/0001553350-26-000087.md) | [153](/filings/0001079973-26-001097.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 154,167,255 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001079973-26-001097.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.